Your browser doesn't support javascript.
loading
Caution with the use of dexamethasone in patients with COVID-19 in its initial phases.
Callejas Rubio, J L; Aomar Millan, I; Moreno-Higueras, M; Martín Ripoll, L; Yuste Osorio, E; Ríos-Fernández, R.
Affiliation
  • Callejas Rubio JL; Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Universitario Clínico San Cecilio, Granada, Spain. Electronic address: jlcalleja@telefonica.net.
  • Aomar Millan I; Servicio de Medicina Interna, Hospital Universitario Clínico San Cecilio, Granada, Spain.
  • Moreno-Higueras M; Servicio de Medicina Interna, Hospital Universitario Clínico San Cecilio, Granada, Spain.
  • Martín Ripoll L; Servicio de Neumología, Hospital Universitario Clínico San Cecilio, Granada, Spain.
  • Yuste Osorio E; Servicio de Cuidados Intensivos, Hospital Universitario Clínico San Cecilio, Granada, Spain.
  • Ríos-Fernández R; Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Universitario Clínico San Cecilio, Granada, Spain.
Rev Clin Esp (Barc) ; 221(10): 592-595, 2021 12.
Article in En | MEDLINE | ID: mdl-34563488
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: En Journal: Rev Clin Esp (Barc) Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: En Journal: Rev Clin Esp (Barc) Year: 2021 Document type: Article